Abstract
In this study, we summarize our long-term follow-up data of 24 patients who underwent autologous peripheral blood stem cell transplantation (PBSCT) using the dump-freezing method in a −80°C freezer. Collected peripheral blood mononuclear cells were mixed with a cryoprotectant solution consisting of autologous plasma and 20% dimethyl sulfoxide, then placed in a −80°C freezer. The recovery rate of mononuclear cells (MNCs), colony-forming unit—granulocyte/macrophage (CFU-GM) colonies, and CD34+ cells were calculated. Engraftment time (with neutrophil count > 0.5 × 109/L, platelet count > 50 ×109/L) and normal hemopoiesis (neutrophil count > 2 ×109/L, platelet count > 100 ×109/L) were evaluated. Median duration of cryopreservation was 76 days. The mean recovery rates of MNCs, CFU-GM colonies, and CD34+ cells were 93.4%, 78.4%, and 95.3%, respectively. The median engraftment times of neutrophils and platelets were 8 and 27 days, respectively. The median normal hemopoiesis times of neutrophil and platelet were 31 and 45 days, respectively. Nine patients are alive and in complete remission (CR). Seven patients in first CR sustained normal hemopoiesis with a median duration of 35 months. Two patients, who achieved second CR after salvage chemotherapy due to a leukemia relapse after PBSCT, maintained engraftment status for 24 and 28 months, and 1 reached normal hemopoiesis. These results demonstrate that PBSCT using the dump-freezing method in a −80°C freezer leads to acceptable long-term engraftment stability.
Similar content being viewed by others
References
Makino S, Harada M, Akashi K, et al. A simplified method for cryopreservation of peripheral blood stem cells at −80°C without rate-controlled freezing.Bone Marrow Transplant. 1991;8:239–244.
Galmes A, Besalduch J, Bargay J, et al. A simplified method for cryopreservation of hematopoietic stem cells with −80°C mechanical freezer with dimethyl sulfoxide as the sole cryoprotectant.Leuk Lymphoma. 1995;17:181–184.
Feremans WW, Bastin G, Le Moine F, et al. Simplification of the blood stem cell transplantation (BSCT) procedure: large volume apheresis and uncontrolled rate cryopreservation at −80°C.Eur J Haematol. 1996;56:278–282.
Katayama Y, Yano T, Bessho A, et al. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells.Bone Marrow Transplant. 1997;19:283–287.
Hernandez-Navarro F, Ojeda E, Arrieta R, et al. Hematopoietic cell transplantation using plasma and DMSO without HES, with non-programmed freezing by immersion in a methanol bath: results in 213 cases.Bone Marrow Transplant. 1998;21:511–517.
Cilloni D, Garau D, Regazzi E, et al. Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing.Bone Marrow Transplant. 1999;23:497–503.
Galmes A, Besalduch J, Bargay J, et al. Long-term storage at −80°C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant.Transfusion. 1999;39:70–73.
Kim BS, Shin SW, Kim YH, et al. The evaluation of functional recovery and transplantation result of frozen thawed hematopoietic stem cells stored at −80°C without rate controlled freezing [abstract].The 5th Asia-Pacific Congress on Bone Marrow Transplantation, Program & Abstract. Seoul, Korea: Asia-Pacific Congress of Bone Marrow Transplantation, September 19–20, 1996: 113.
Stiff PJ, Koester AR, Weidner MK, Dvorak K, Fisher RI. Autologous bone marrow transplantation using unfractionated cells cryo-preserved in dimethylsulfoxide and hydroxy- ethyl starch without controlled-rate freezing.Blood. 1987;70:974–978.
Schulman KA, Birch R, Zhen B, Pania N, Weaver CH. Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support.J Clin Oncol. 1999;17:1227.
Indovina A, Majolino I, Buscemi F, et al. Engraftment kinetics and long-term stability of hemopoiesis following autografting of peripheral blood stem cells.Haematologica. 1995;80:115–122.
Amadori S, Arcese W, Isacchi G, et al. Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia.J Clin Oncol. 1991;19:1210–1214.
Spadea A, Petti MC, Fazi P, et al. Mitoxantrone, etoposide, and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia.Leukemia. 1993;7:549–552.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Choi, C.W., Kim, B.S., Seo, J.H. et al. Long-Term Engraftment Stability of Peripheral Blood Stem Cells Cryopreserved Using the Dump-Freezing Method in a −80°C Mechanical Freezer with 10% Dimethyl Sulfoxide. Int J Hematol 73, 245–250 (2001). https://doi.org/10.1007/BF02981945
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02981945